An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus - PubMed (original) (raw)

Jianwei Wang, Qiang Wei, Mingpeng She, Wayne A Marasco, Hong Jiang, Xinming Tu, Hua Zhu, Lili Ren, Hong Gao, Li Guo, Lan Huang, Renquan Yang, Zhe Cong, Lan Guo, Yanbin Wang, Yali Liu, Yili Sun, Shumin Duan, Jianguo Qu, Liangbiao Chen, Wei Tong, Li Ruan, Peimao Liu, Hua Zhang, Jianmin Zhang, Huiyuan Zhang, Depei Liu, Qian Liu, Tao Hong, Wei He

Affiliations

An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus

Chuan Qin et al. J Pathol. 2005 Jul.

Abstract

A new SARS animal model was established by inoculating SARS coronavirus (SARS-CoV) into rhesus macaques (Macaca mulatta) through the nasal cavity. Pathological pulmonary changes were successively detected on days 5-60 after virus inoculation. All eight animals showed a transient fever 2-3 days after inoculation. Immunological, molecular biological, and pathological studies support the establishment of this SARS animal model. Firstly, SARS-CoV-specific IgGs were detected in the sera of macaques from 11 to 60 days after inoculation. Secondly, SARS-CoV RNA could be detected in pharyngeal swab samples using nested RT-PCR in all infected animals from 5 days after virus inoculation. Finally, histopathological changes of interstitial pneumonia were found in the lungs during the 60 days after viral inoculation: these changes were less marked at later time points, indicating that an active healing process together with resolution of an acute inflammatory response was taking place in these animals. This animal model should provide insight into the mechanisms of SARS-CoV-related pulmonary disease and greatly facilitate the development of vaccines and therapeutics against SARS.

Copyright 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

PubMed Disclaimer

Figures

Figure 1

Figure 1

SARS‐CoV antigen in lung tissues from infected Macaca mulatta (No 1951) 10 days after infection. Lung tissue samples were stained using an avidin–biotin complex peroxidase technique. Sections were incubated with monoclonal antibodies against SARS‐CoV (1 : 400) and were developed using biotin‐labelled goat anti‐mouse antibody. (Immunohistochemical staining; original magnification ×400)

Figure 2

Figure 2

Macroscopic appearance of lung tissue of SARS‐CoV‐infected monkey 2373 on the fifth day after infection; local lesions are arrowed

Figure 3

Figure 3

Lung alveoli of a normal healthy rhesus monkey for comparison. (A) Normal alveolar septa (H&E; original magnification ×200). (A, a) The inter‐alveolar septa are narrow; there is no inflammatory cell infiltration or oedema (H&E; original magnification ×200). (A, b) The alveolar sacs are clear; no inflammatory cells are seen in any of the alveoli shown (H&E; original magnification ×200). Panel B, a shows intact reticulin fibres in the alveolar septa; B, b shows small capillaries located in the inter‐alveolar septa (MCT; original magnification ×400). Panel C shows the intact lining epithelium; C, a, b shows positive staining of epithelial cells with a monoclonal anti‐cytokeratin antibody (CK +; original magnification ×1000). Panel D, a, b shows that foam cells staining positive for CD68 are adherent to regenerating epithelial cells (MAb against human CD68; original magnification ×1000)

Figure 4

Figure 4

Monkey 2373, 5 days after infection. (A, a) Interstitial pneumonia with haemorrhage; (A, b) foam cells (macrophages) with engulfed red blood cells in the cytoplasm (H&E; original magnification ×200). (B, a) Interstitial pneumonia: macrophage infiltration is remarkable, with engulfed red blood cells in their cytoplasm; (B, b) lymphocytes and fibrin deposition; (B, c) pleuritis with oedema, phagocyte and lymphocyte infiltration (H&E; original magnification ×200). (C, a) Haemorrhage; (C, b) macrophages; (C, c) lymphocytes and macrophages (H&E; original magnification ×200). (D, a) Macrophages packed in the alveolus; (D, b) lymphocytes; (D, c) foam cells (H&E; original magnification ×400)

Figure 5

Figure 5

Monkey 1924, 7 days after infection. (A, a) Haemorrhage in the inter‐alveolar septum; (A, b) engulfed red blood cells in phagocytes; (A, c) alveoli filled with fibrin, inflammatory cells, and red blood cells; (A, d) lung oedema (HE; original magnification ×400). (B, a) Macrophage with engulfed red blood cell; (B, b) foam cells; (B, c) lymphocytes (H&E; original magnification ×1000). (C, a) Interstitial pneumonia; (C, b) distended air sacs; (C, c) dilatation of respiratory duct (H&E; original magnification ×200). (D, a) Macrophages; (D, b) lymphocytes in the inter‐alveolar septum (H&E; original magnification ×1000)

Figure 6

Figure 6

Monkey 1951, 10 days after infection. (A, a) Granulation tissue in the damaged bronchiolar wall; (A, b) proliferation of the lining epithelial cells; (A, c) early regeneration of the damaged epithelium (H&E; original magnification ×200). (B, a) Phagocytes; (B, b) lymphocytes (H&E; original magnification ×400). (C, a) Lung oedema; (C, b) interstitial pneumonia; (C, c) foam cells (H&E; original magnification ×400). (D, a) Fragmentation of reticulin fibres in the alveolar wall; (D, b) desquamation of epithelial cells (Gomori's stain; ×1000)

Figure 7

Figure 7

Monkey 883, 15 days after infection. (A, a) Interstitial pneumonia with haemorrhage and fibrin deposition; (A, b) phagocytes with red blood cell engulfment; (A, c) capillary congestion (H&E; original magnification ×200). (B, a) Presence of fibrin filaments between neighbouring alveoli; (B, b) red blood cells engulfed in phagocytes; (B, c) foam cells (H&E; original magnification ×400). (C, a) Lung oedema; (C, b) accumulation of phagocytes in alveoli; (C, c) lymphocytes in the alveolar septum and the alveoli (H&E; original magnification ×400). (D, a) Interstitial pneumonia present in monkey 227

Figure 8

Figure 8

Monkey 1921, 30 days after infection. (A, a) Interstitial pneumonia with mononuclear cell infiltration; (A, b) localized emphysema (H&E; original magnification ×100). (B, a) Focal liver necrosis (No 1921); (B, b) degenerate and necrotic cells; (B, c) lymphocytes; (B, d) liver cells. (C, a) Regenerative epithelial cells shown to be CK‐positive (cytokeratin MAb stain; original magnification ×1000); (C, b) macrophages. (D, a) CD68‐positive cells (macrophages) adherent to the surface of regenerative epithelial cells (CD68 MAb stain; original magnification ×1000); (D, b) regenerative epithelial cells in small bronchioles

Figure 9

Figure 9

Monkeys 900 and 2372, 60 days after infection. (A, a) Interstitial pneumonia with mononuclear infiltration (H&E; original magnification ×50) (No 2372). (A, b) Some alveoli are distended. (B, a) Mild interstitial pneumonia; (B, b) emphysema (H&E; original magnification × 100) (No 900). (C, a) Interstitial pneumonia and infiltration of mononuclear cells; (C, b) foam cell formation (H&E; original magnification ×200). (D, a) Foam cells in alveoli; (D, b) phagocytes; (D, c) lymphocytes in septa (H&E; original magnification ×400)

Similar articles

Cited by

References

    1. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS‐associated coronavirus. Science 2003; 300: 1399–1404. - PubMed
    1. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967–1976. - PubMed
    1. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953–1966. - PubMed
    1. Calza L, Manfredi R, Verucchi G, et al. SARS: a new emergency in the world health. Recent Prog Med 2003; 94: 284–294. - PubMed
    1. Chiu RW, Chim SS, Lo YM. Molecular epidemiology of SARS—from Amoy Gardens to Taiwan. N Engl J Med 2003; 349: 1875–1876. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources